About US
   
Home ￤ About us
ProfoundBio Overview
ProfoundBio is a clinical stage biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.

Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple candidates that are currently in discovery, preclinical development, and clinical stage targeting a broad range of tumors. ​
Our Mission
Aiming to help patients with cancer through discovery and development of novel targeted therapy with curative potential.

We are focused on discovering and advancing novel antibody-based therapeutic agents with diverse mechanisms of action in treating patients with a broad range of cancers.

Our team of experienced scientists and clinicians take a fresh look at how  best to eradicate cancer and a creative approach to drug discovery and development in rapidly bringing novel therapy to patients.​

Our Core Values

Integrity        Trust        Respect        Teamwork